UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Don’t Stop Post–Sustained Virologic Response Hepatocellular Carcinoma Surveillance Just Yet

Clinical infectious diseases, 2020-12, Vol.71 (9), p.2363-2364

2020

Volltextzugriff (PDF)

Eradication of hepatitis C virus profoundly prolongs survival in hepatocellular carcinoma patients receiving transarterial chemoembolization

Journal of viral hepatitis, 2017-12, Vol.24 (12), p.1160-1167

2017

Volltextzugriff (PDF)

Correlates of HIV sustained viral suppression in HIV/hepatitis C virus coinfected patients: possible role of the hepatitis C virus sustained viral response

AIDS (London), 2014-05, Vol.28 (8), p.1155-1160

2014

Volltextzugriff (PDF)

Status of Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection and Remaining Challenges

Gastroenterology (New York, N.Y. 1943), 2019-01, Vol.156 (2), p.431-445

2019

Volltextzugriff (PDF)

Clinical Characteristics and Outcomes in People Living With Human Immunodeficiency Virus Hospitalized for Coronavirus Disease 2019

Clinical infectious diseases, 2020-11, Vol.71 (16), p.2294-2297

2020

Volltextzugriff (PDF)

Antiretroviral Adherence Level Necessary for HIV Viral Suppression Using Real-World Data

Journal of acquired immune deficiency syndromes (1999), 2019-11, Vol.82 (3), p.245-251

2019

Volltextzugriff (PDF)

Long-Term Treatment Outcomes of Patients Infected With Hepatitis C Virus: A Systematic Review and Meta-analysis of the Survival Benefit of Achieving a Sustained Virological Response

Clinical infectious diseases, 2015-09, Vol.61 (5), p.730-740

2015

Volltextzugriff (PDF)

Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting

The lancet HIV, 2019-04, Vol.6 (4), p.e259-e268

2019

Volltextzugriff (PDF)

Adherence to Once-daily and Twice-daily Direct-acting Antiviral Therapy for Hepatitis C Infection Among People With Recent Injection Drug Use or Current Opioid Agonist Therapy

Clinical infectious diseases, 2020-10, Vol.71 (7), p.e115-e124

2020

Volltextzugriff (PDF)

Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysis

Clinical infectious diseases, 2016-03, Vol.62 (6), p.683-694

2016

Volltextzugriff (PDF)

Liver Fibrosis in Human Immunodeficiency Virus (HIV)-Hepatitis C Virus (HCV) Coinfection Before and After Sustained Virologic Response: What Is the Best Noninvasive Marker for Monitoring Regression?

Clinical infectious diseases, 2021-08, Vol.73 (3), p.468-477

2021

Volltextzugriff (PDF)

Direct-Acting Antiviral–Induced Hepatitis C Virus Clearance Does Not Completely Restore the Altered Cytokine and Chemokine Milieu in Patients With Chronic Hepatitis C

The Journal of infectious diseases, 2016-12, Vol.214 (12), p.1965-1974

2016

Volltextzugriff (PDF)

Viral suppression rates in a safety-net HIV clinic in San Francisco destabilized during COVID-19

AIDS (London), 2020-12, Vol.34 (15), p.2328-2331

2020

Volltextzugriff (PDF)

Mortality in hepatitis C virus-cured vs. hepatitis C virus-uninfected people with HIV

AIDS (London), 2023-07, Vol.37 (8), p.1297-1306

2023

Volltextzugriff (PDF)

Efficacy of Direct-acting Antivirals for Chronic Hepatitis C Virus Infection in People Who Inject Drugs or Receive Opioid Substitution Therapy: A Systematic Review and Meta-analysis

Clinical infectious diseases, 2020-05, Vol.70 (11), p.2355-2365

2020

Volltextzugriff (PDF)

Dolutegravir versus ritonavir-boosted lopinavir both with dual nucleoside reverse transcriptase inhibitor therapy in adults with HIV-1 infection in whom first-line therapy has failed (DAWNING): an open-label, non-inferiority, phase 3b trial

The Lancet infectious diseases, 2019-03, Vol.19 (3), p.253-264

2019

Volltextzugriff (PDF)

Regression of fibrosis and portal hypertension in HCV-associated cirrhosis and sustained virologic response after interferon-free antiviral therapy

Journal of viral hepatitis, 2016-12, Vol.23 (12), p.994-1002

2016

Volltextzugriff (PDF)

Last Mile to Microelimination of Hepatitis C Virus Infection Among People Living With Human Immunodeficiency Virus

Clinical infectious diseases, 2021-10, Vol.73 (7), p.e2172-e2174

2021

Volltextzugriff (PDF)

Liver Stiffness at the Time of Sustained Virological Response Predicts the Clinical Outcome in People Living With Human Immunodeficiency Virus and Hepatitis C Virus With Advanced Fibrosis Treated With Direct-acting Antivirals

Clinical infectious diseases, 2020-12, Vol.71 (9), p.2354-2362

2020

Volltextzugriff (PDF)

No overall change in the rate of weight gain after switching to an integrase-inhibitor in virologically suppressed adults with HIV

AIDS (London), 2020-01, Vol.34 (1), p.109-114

2020

Volltextzugriff (PDF)

Durable Viral Suppression and Transmission Risk Potential Among Persons With Diagnosed HIV Infection: United States, 2012–2013

Clinical infectious diseases, 2016-10, Vol.63 (7), p.976-983

2016

Volltextzugriff (PDF)

Generalized anxiety disorder symptoms among persons with diagnosed HIV in the United States

AIDS (London), 2019-09, Vol.33 (11), p.1781-1787

2019

Volltextzugriff (PDF)

Management of Virologic Failure and HIV Drug Resistance

Infectious disease clinics of North America, 2019-09, Vol.33 (3), p.707-742

2019

Volltextzugriff (PDF)

Change in Fibrosis 4 Index as Predictor of High Risk of Incident Hepatocellular Carcinoma After Eradication of Hepatitis C Virus

Clinical infectious diseases, 2021-11, Vol.73 (9), p.e3349-e3354

2021

Volltextzugriff (PDF)

From Care to Cure: Demonstrating a Model of Clinical Patient Navigation for Hepatitis C Care and Treatment in High-Need Patients

Clinical infectious diseases, 2017-03, Vol.64 (5), p.685-691

2017

Volltextzugriff (PDF)

1 – 25 von 552

Suche als RSS-Feed

Aktive Filter

ThemaInfectious Diseases

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(545)
Mit Volltextzugriff
(477)

Publikationsform

Artikel
(552)

Sprache

Erscheinungsjahr

n.n

Thema

Sustained Virologic Response
(551)
Science & Technology
(546)
Life Sciences & Biomedicine
(536)
Humans
(510)
Male
(374)
Female
(363)
Middle Aged
(311)
Adult
(288)
Antiviral Agents - Therapeutic Use
(243)
Immunology
(239)
Virology
(229)
Hepatitis C, Chronic - Drug Therapy
(221)
Hiv Infections - Drug Therapy
(216)
Treatment Outcome
(212)
Hepatitis C
(206)
Hiv
(178)
Aged
(146)
Human Immunodeficiency Virus
(143)
Hepatitis
(141)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Don’t Stop Post–Sustained Virologic Response Hepatocellular Carcinoma Surveillance Just Yet

Eradication of hepatitis C virus profoundly prolongs survival in hepatocellular carcinoma patients receiving transarterial chemoembolization

Correlates of HIV sustained viral suppression in HIV/hepatitis C virus coinfected patients: possible role of the hepatitis C virus sustained viral response

Status of Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection and Remaining Challenges

Clinical Characteristics and Outcomes in People Living With Human Immunodeficiency Virus Hospitalized for Coronavirus Disease 2019

Antiretroviral Adherence Level Necessary for HIV Viral Suppression Using Real-World Data

Long-Term Treatment Outcomes of Patients Infected With Hepatitis C Virus: A Systematic Review and Meta-analysis of the Survival Benefit of Achieving a Sustained Virological Response

Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting

Adherence to Once-daily and Twice-daily Direct-acting Antiviral Therapy for Hepatitis C Infection Among People With Recent Injection Drug Use or Current Opioid Agonist Therapy

Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysis

Liver Fibrosis in Human Immunodeficiency Virus (HIV)-Hepatitis C Virus (HCV) Coinfection Before and After Sustained Virologic Response: What Is the Best Noninvasive Marker for Monitoring Regression?

Direct-Acting Antiviral–Induced Hepatitis C Virus Clearance Does Not Completely Restore the Altered Cytokine and Chemokine Milieu in Patients With Chronic Hepatitis C

Viral suppression rates in a safety-net HIV clinic in San Francisco destabilized during COVID-19

Mortality in hepatitis C virus-cured vs. hepatitis C virus-uninfected people with HIV

Efficacy of Direct-acting Antivirals for Chronic Hepatitis C Virus Infection in People Who Inject Drugs or Receive Opioid Substitution Therapy: A Systematic Review and Meta-analysis

Dolutegravir versus ritonavir-boosted lopinavir both with dual nucleoside reverse transcriptase inhibitor therapy in adults with HIV-1 infection in whom first-line therapy has failed (DAWNING): an open-label, non-inferiority, phase 3b trial

Regression of fibrosis and portal hypertension in HCV-associated cirrhosis and sustained virologic response after interferon-free antiviral therapy

Last Mile to Microelimination of Hepatitis C Virus Infection Among People Living With Human Immunodeficiency Virus

Liver Stiffness at the Time of Sustained Virological Response Predicts the Clinical Outcome in People Living With Human Immunodeficiency Virus and Hepatitis C Virus With Advanced Fibrosis Treated With Direct-acting Antivirals

No overall change in the rate of weight gain after switching to an integrase-inhibitor in virologically suppressed adults with HIV

Durable Viral Suppression and Transmission Risk Potential Among Persons With Diagnosed HIV Infection: United States, 2012–2013

Generalized anxiety disorder symptoms among persons with diagnosed HIV in the United States

Management of Virologic Failure and HIV Drug Resistance

Change in Fibrosis 4 Index as Predictor of High Risk of Incident Hepatocellular Carcinoma After Eradication of Hepatitis C Virus

From Care to Cure: Demonstrating a Model of Clinical Patient Navigation for Hepatitis C Care and Treatment in High-Need Patients

Aktive Filter

Suchergebnisse filtern